Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer

Andy Göbel(German Cancer Research Center), Tilman D. Rachner(Technische Universität Dresden)
BMC Cancer
July 29, 2020
Cited by 50


Related Papers